Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Mise à jour : Il y a 4 ans
Référence : NCT01191086

Femme et Homme

Extrait

The purpose of this study is to examine the safety of USL255 as adjunctive therapy in patients with refractory partial onset-seizures.


Critère d'inclusion

  • Epilepsy